Millennium Management’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Other funds holding TNYA
VCM
EAM
BGM
KCM
ACM
Millennium Management's TNYA Position: Q1 2026 in Review
Millennium Management increased its Tenaya Therapeutics (TNYA) stake by 18% in Q1 2026, buying an estimated $621K and bringing the position to 5,456,666 shares worth $3.78M. The position accounts for ﹤0.01% of the portfolio, ranked #3247.
Millennium Management first reported a position in TNYA in Q3 2021 and has held it in 17 quarters since. The position peaked at $7.3M in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.
- Millennium Management held 5,456,666 shares of Tenaya Therapeutics worth $3.78M as of Q1 2026.
- Millennium Management bought 840,920 Tenaya Therapeutics shares in Q1 2026, an estimated $621K.
- Tenaya Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3247 holding.
- Millennium Management first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 17 quarters since.
- Millennium Management's Tenaya Therapeutics position peaked at $7.3M in Q3 2025.
- 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.